Global Acute Ischemic Stroke Diagnosis and Treatment market – market forecast, market trend, market research and opportunity, size and share 2014-2027

Overview

The Global Acute Ischemic Stroke Diagnosis and Treatment Market to Expand at 6.3% CAGR.

Acute ischemic stroke alludes to a sudden loss of certain brain function attributable to uneven or lack of blood to the brain. Acute ischemic stroke constitutes 78%-87% of the total strokes occur worldwide. There are two types of acute ischemic stroke namely, thrombotic stroke, and embolic stroke. Acute ischemic functions are basically activated by atherosclerosis plaques blocking veins, blood clots locking the blood distribution to or from arteries nourishing the brain, or narrowing of veins of the brain. Acute ischemic stroke is one of the significant reasons for perpetual inability in the patients. It is additionally the third biggest reason of death around the world. Acute ischemic stroke can impact people of all age-groups. In any case, acute ischemic stroke most regularly impact people, who are over 60 years, the danger of acute ischemic stroke increments with age. Driven by the technical advancement in diagnosis, the acute ischemic stroke analysis and treatment request is predicted to undergo an escalating demand in coming years

The two main considerations moving the development of the acute ischemic stroke diagnosis and treatment market are; huge patient pools and a concerning ascend in population at a higher danger of developing stroke sooner rather than later. Rising frequency of diabetes alongside high tobacco users and increase in the geriatric population are noteworthy variables that decide the market development. Nonetheless, the high cost of treatment, lack of reimbursement arrangements, and constrained accessibility of expertise; are probably going to limit the market growth

The development in the surgical devices technology, additionally with the rising prevalence of acute ischemia stroke cases among the patients is acting as dominant driving component for the surgery in acute stroke treatment. A portion of alternate elements driving the market predominantly incorporate, geriatric population in the developed nations of Europe and North America. The advancement of the viable medicine in the treatment of ischemic stroke will hinder the acknowledgment of costly surgery in the ischemic stroke diagnosis market. The advancement of desmoteplase, a novel cutting edge thrombolytic, is one of the significant progression of in the treatment innovation of acute ischemic stroke. It gives extended therapeutic time contrasted with the greater part of the other treatment strategy. In addition, with the expanding effect of telemedicine, e-medicinal adherence, and e-prescription the intense ischemic stroke diagnosis and treatment market is relied upon to thrive at a sound rate amid the figure time frame i.e. forecast period.

The approach of genomic medicine is one of the key patterns that will pick up footing in the acute ischemic stroke therapeutics market. Genomic medication enables specialists to settle on better diagnostic and therapeutic decisions. The rise of genomic prescription additionally brought about the advancement of customized drug and epigenomics, which will help make a more exact diagnosis of diseases.

 

Facts related to acute ischemic stroke:

  1. Men are at higher risk of acute ischemic stroke as compared to women.
  2. 85% of acute ischemic stroke survive their stay in hospital.
  3. Worldwide every 2 seconds, someone is having stroke.
  4. Stroke is the second most common death in the world.
  5. In 2010, there were 17 Million incidences of stroke.

The global ischemic stroke diagnosis and treatment market is divided on the basis of diagnostic type, therapeutic type and geography. According to diagnostic type, the market is segmented into Computed Tomography Scan (CT scan), Magnetic Resonance Imaging (MRI), Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography and Blood tests. Based on therapeutic type, the market is segmented into Tissue Plasminogen Activator, Anticoagulant, Antiplatelet and Antihypertensive. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific, and Rest of World.

 

Market Dynamics

Drivers

  • Rise in incidence of ischemic stroke
  • Rise in number of diabetes, hypertension, lipid disorders, obesity and tobacco use
  • Rapid growth in geriatric population

Restraints

  • Lack of reimbursement policies
  • Lack of skilled professionals

Report Key Benefits

datos-market-post-rd1

Table of Content

  1. Market Introduction
    • Market Definition
    • Market Scope
    • Market Segments
    • Key Market Players
    • Report Key Benefits
  2. Research Methodology
    • Research Process
    • Market Estimations and Trend Analysis
    • Executive Summary
  3. Market Dynamics
    • Market Share Analysis
    • Porter’s Five Forces
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Facts for Acute Ischemic Stroke
    • 11 year epidemiological forecast data
    • Incidence of acute ischemic stroke
      • Age-based
      • Sex-based
    • Prevalence rate of acute ischemic stroke
      • Age-based
      • Sex-based
  1. Global Acute Ischemic Stroke Diagnosis and Treatment Market by Diagnostic Type
    • Market Overview, by Diagnostics Type
      • Computed Tomography (CT)
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
      • Carotid Ultrasound
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
      • Electrocardiography
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
      • Echocardiography
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
      • Cerebral Angiography
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
      • Magnetic Resonance Imaging (MRI)
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
      • Others
        • Overview
        • Market Share, 2016
        • Market Size and Forecast
  1. Global Acute Ischemic Stroke Diagnosis and Treatment Market by Therapeutic Type
    • Market Overview, by Therapeutic Type
      • Tissue Plasminogen Activator
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Antiplatelet
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Antihypertensive
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Anticoagulant
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027

 

  1. Global Acute Ischemic Stroke Diagnosis and Treatment Market by Geography
    • Market Overview by Geography
    • North America
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
      • U.S
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Canada
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
      • Mexico
        • Overview
        • Market Share, 2016
        • Market Size , 2014-2027
      • Europe
        • Overview
        • Market Share, 2016
        • Market Size, 2014-2027
        • Germany
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • UK
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • France
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • Spain
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • Italy
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
        • Rest of Europe
          • Overview
          • Market Share, 2016
          • Market Size, 2014-2027
  • Asia-Pacific
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
    • Japan
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • China
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • India
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Australia
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • South Korea
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Rest of Asia-Pacific
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
  • Rest Of World
    • Overview
    • Market Share, 2016
    • Market Size, 2014-2027
    • Brazil
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Argentina
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • South Africa
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Middle East
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027
    • Others
      • Overview
      • Market Share, 2016
      • Market Size, 2014-2027

 

  1. Company Profiles
    • Medtronic plc
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Boston Scientific Corporation
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Koninklijke Philips N.V
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Cordis Corporation
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Merck & Co., Inc.
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Siemens AG
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Abbott Laboratories
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Stryker Corporation
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • Genentech, Inc
      • Overview
      • Financials
      • Business Segments
      • Recent Developments
    • GE Healthcare
      • Overview
      • Financials
      • Business Segments
      • Recent Developments

List of Tables

Table 1: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 2: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Computed Tomography (CT), by Geography, 2014-2027, (Million USD)

Table 3: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Carotid Ultrasound, by Geography, 2014-2027, (Million USD)

Table 4: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Electrocardiography, by Geography, 2014-2027, (Million USD)

Table 5: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Echocardiography, by Geography, 2014-2027, (Million USD)

Table 6: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Cerebral Angiography, by Geography, 2014-2027, (Million USD)

Table 7: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Magnetic resonance imaging (MRI), by Geography, 2014-2027, (Million USD)

Table 8: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Others, by Geography, 2014-2027, (Million USD)

Table 9: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 10: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Tissue Plasminogen Activator, by Geography, 2014-2027, (Million USD)

Table 11: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Antiplatelet, by Geography, 2014-2027, (Million USD)

Table 12: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Antihypertensive, by Geography, 2014-2027, (Million USD)

Table 13: Global Acute Ischemic Stroke Diagnosis and Treatment Market, for Anticoagulant, by Geography, 2014-2027, (Million USD)

Table 14: Global Acute Ischemic Stroke Diagnosis and Treatment Market, by Geography, 2014-2027, (Million USD)

Table 15: North America Acute Ischemic Stroke Diagnosis and Treatment Market, by Country, 2014-2027, (Million USD)

Table 16: North America Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 17: North America Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 18: U.S. Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 19: U.S. Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 20: Canada Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 21: Canada Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 22: Mexico Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 23: Mexico Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 24: Europe Acute Ischemic Stroke Diagnosis and Treatment Market, by Country, 2014-2027, (Million USD)

Table 25: Europe Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 26: Europe Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 27: Germany Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, by Geography, 2014-2027, (Million USD)

Table 28: Germany Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, by Geography, 2014-2027, (Million USD)

Table 29: UK Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, by Geography, 2014-2027, (Million USD)

Table 30: UK Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, by Geography, 2014-2027, (Million USD)

Table 31: France Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, by Geography, 2014-2027, (Million USD)

Table 32: France Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 33: Spain Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 34: Spain Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 35: Italy Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 36: Italy Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 37: Rest of Europe Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 38: Rest of Europe Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 39: Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market, by Country, 2014-2027, (Million USD)

Table 40: Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 41: Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 42: Japan Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 43: Japan Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 44: China Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 45: China Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 46: India Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 47: India Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 48: Australia Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 49: Australia Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 50: South Korea Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 51: South Korea Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 52: Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 53: Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 54: Rest of World Acute Ischemic Stroke Diagnosis and Treatment Market, by Country, 2014-2027, (Million USD)

Table 55: Rest of World Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 56: Rest of World Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 57: Brazil Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 58: Brazil Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 59: Argentina Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 60: Argentina Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 61: South Africa Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 62: South Africa Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 63: Middle East Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 64: Middle East Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 65: Others Acute Ischemic Stroke Diagnosis and Treatment Market, by Diagnostic Type, 2014-2027, (Million USD)

Table 66: Others Acute Ischemic Stroke Diagnosis and Treatment Market, by Therapeutic Type, 2014-2027, (Million USD)

Table 67: Medtronic plc, Overview, 2014-2027, (Million USD)

Table 68: Boston Scientific Corporation, Overview, 2014-2027, (Million USD)

Table 69: Koninklijke Philips N.V, Overview, 2014-2027, (Million USD)

Table 70: Cordis Corporation, Overview, 2014-2027, (Million USD)

Table 71: Siemens AG, Overview, 2014-2027, (Million USD)

Table 72: Abbott Laboratories, Overview, 2014-2027, (Million USD)

Table 73: Stryker Corporation, Overview, 2014-2027, (Million USD)

Table 74: Genentech, Inc, Overview, 2014-2027, (Million USD)

Table 75: GE Healthcare, Overview, 2014-2027, (Million USD)

Table 76: Merck & Co., Inc., Overview, 2014-2027, (Million USD)

List of Figures

Figure 1. Global Acute Ischemic Stroke Diagnosis and Treatment Market Segments

Figure 2. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share Analysis

Figure 3. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Computed Tomography (CT), 2016, (%)

Figure 4. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Carotid Ultrasound, 2016, (%)

Figure 5. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Electrocardiography, 2016, (%)

Figure 6. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Echocardiography, 2016, (%)

Figure 7. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Cerebral Angiography, 2016, (%)

Figure 8. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Magnetic resonance imaging (MRI), 2016, (%)

Figure 9. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Others, 2016, (%)

Figure 10. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Tissue Plasminogen Activator, 2016, (%)

Figure 11. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Antiplatelet, 2016, (%)

Figure 12. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Antihypertensive, 2016, (%)

Figure 13. Global Acute Ischemic Stroke Diagnosis and Treatment Market Share for Anticoagulant, 2016, (%)

Figure 14. North America Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 15. North America Acute Ischemic Stroke Diagnosis and Treatment Market by Country, 2014-2027, (Million USD)

Figure 16. U.S. Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 17. Canada Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 18. Mexico Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 19. Europe Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 20. Europe Acute Ischemic Stroke Diagnosis and Treatment Market by Country, 2014-2027, (Million USD)

Figure 21. Germany Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 22. UK Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 23. France Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 24. Spain Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 25. Italy Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 26. Rest of Europe Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 27. Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 28. Asia=Pacific Acute Ischemic Stroke Diagnosis and Treatment Market by Country, 2014-2027, (Million USD)

Figure 29. Japan Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 30. China Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 31. India Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 32. Australia Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 33. South Korea Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 34. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 35. Rest of World Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 36. Rest of World Acute Ischemic Stroke Diagnosis and Treatment Market by Country, 2014-2027, (Million USD)

Figure 37. Brazil Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 38. Argentina Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 39. South Africa Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 40. Middle East Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Figure 41. Others Acute Ischemic Stroke Diagnosis and Treatment Market Share, 2016, (%)

Market Segments

By Diagnostic Type

  • Computed Tomography (CT)
  • Carotid Ultrasound
  • Electrocardiography
  • Echocardiography
  • Cerebral Angiography
  • Magnetic resonance imaging (MRI)
  • Others

By Therapeutic Type

  • Tissue Plasminogen Activator
  • Antiplatelet
  • Antihypertensive
  • Anticoagulant

By Region

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest Of World
    • Brazil
    • Argentina
    • South Africa
    • Middle East
    • Others

Company Profiles

  • Medtronic plc
  • Boston Scientific Corporation
  • Koninklijke Philips N.V
  • Cordis Corporation
  • Siemens AG
  • Abbott Laboratories
  • Stryker Corporation
  • Genentech, Inc
  • GE Healthcare
  • Merck & Co., Inc.

Target Audience

  • Manufacturers of Ischemic Stroke Diagnosis and Treatment products.
  • Service providers, dealers, distributors, and suppliers of Stroke Diagnosis and Treatment products.
  • Healthcare institutes.
  • Research institutes, associations and academicians.
  • Market research and consulting firms.
Place an Order

Testimonial

Looking for a Market Analysis Report?